United States Botox Market Report Overview



This report mainly covers the medical and cosmetic Botox type, while we can also offer any product survey report related to the Botox industry chain.

Publisher: QYResearch
Published Date: 2018/6/1




Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined due to its stable property that Botox is used widely in Experimental Research and Clinical Application at the early stage.

In the last several years, United States market of Botox developed rapidly, with an average growth rate of 12.6%. In 2016, United States revenue of Botox is nearly 2100 M USD; the actual sales are about 13.3 million units.

The United States average Price of Botox is in the decreasing trend. With the situation of United States economy, Prices will be in decreasing trend in the following five years.

The classification of Botox includes 50U, 100U and other, and the sales proportion of 50U in 2016 is about 58.8%. Botox is used for medical and cosmetic. Medical was the largest application segment in 2016, the proportion is about 64.6%. 

Pacific Region is the largest consumption place, with a consumption market share nearly 25% in 2016. Following Pacific Region, South Atlantic region is the second largest consumption place with the consumption market share of 21%.

The Botox industry is highly concentrated; there are only three major manufacturers in USA. In the world wide, major manufactures mainly distribute in North America and Europe. The major manufactures are Allergan, Ipsen, Medytox Inc. and Merz Pharmaceuticals; with the development of technology, other companies will have many opportunities

Company mergers and acquisitions, and inter-companies cooperation have occurred for development and growth. As the downstream consumption usually follows with developed and rapid economic growth areas, such as BRICS, the developed areas’ company prefers investing to underdevelopment regions these years. With the global economic recovery, more and more people pay attention to rising environment standards, especially in development of the regions that have a large population and fast economic growth, the need of Botox will increase.


This article was first released by QYResearch, if reproduced, please indicate the source.
Marketing: sales@qyresearch.com
Media Contact: press@qyresearch.com

评论

热门博文